Sophie Baratte
Algemeen Directeur bij CELLNOVO
Actieve functies van Sophie Baratte
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CELLNOVO | Directeur/Bestuurslid | 20-05-2016 | - |
| Algemeen Directeur | 30-01-2016 | - | |
| Investor Relations Contact | 01-01-2014 | - | |
| Voorzitter | 11-04-2016 | 09-06-2016 | |
| Corporate Officer/Principal | 01-01-2014 | - |
Loopbaan van Sophie Baratte
Eerdere bekende functies van Sophie Baratte
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| STENTYS | Directeur/Bestuurslid | 21-03-2017 | 01-03-2021 |
| Independent Dir/Board Member | 21-03-2017 | 01-03-2021 | |
Cellnovo Ltd.
 Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - |
Opleiding van Sophie Baratte
| University of Compiègne | Doctorate Degree |
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Statistieken
Internationaal
| Frankrijk | 5 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Chairman | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France. | Health Technology |
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France. | Health Technology |
Cellnovo Ltd.
Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Health Technology |
- Beurs
- Insiders
- Sophie Baratte
- Ervaring
